Showing 2141 - 2160 de 10235 results
Researchers from the Respiratory biophysics and bioengineering IDIBAPS research group, the Biophysics and Bioengineering Unit of the UB and the1
These are the first results of a global clinical trial in which the Hospital Clinic and ISGlobal participate.
Any infection in a person who suffers diabetes has a double risk: on the one hand, it may decompensate the diabetes itself; and on the other, any com1
Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating h1
The immune system of people with diseases like lupus or rheumatoid arthritis malfunctions and attacks cells in their own bodies. This is why they are1
Lockdown situations can lead to feelings of stress, frustration, guilt, or even anxiety in the general public. Also, people with mental disorders are1
Researchers of IDIBAPS have participated in an interdisciplinary research study of the UB in which there have been identified two potential candidate1
The COVID-19 pandemic has raised concerns about the risk of people with different kinds of immunosuppression developing more serious forms of the inf1
Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better under1
The SARS-CoV2 pandemic has impacted society in very diverse ways. Many people have changed their habits due to lockdown, such as practising physical1
It has been observed that cardiovascular disease and COVID-19 are related in various ways, one of the most dangerous of which is patients with heart1
People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and t1
During the COVID-19 pandemic, allergists and other specialists such as pulmonologists, ENT specialists, internists and dermatologists have attended t1
Thrombosis, especially venous thrombosis, are one of the serious complications that can appear in patients affected by COVID-19. These complicat1
The pandemic and lockdown caused by COVID-19 have increased symptoms of anxiety and depression in the population. However, according to a major surve1
In a retrospective study with 80 kidney transplant patients with COVID-19, treatment with tocilizumab demonstrates a decrease in one of the inflammat1
Approximately 800,000 children and 1 million elderly people died of pneumonia around the world in 2017. Nevertheless, the severity of pneumonia is of1
COVID-19 affects people with Parkinson’s disease in a similar way to the general population, but it may be more serious in cases of advanced disease.1
Active smokers who have chronic obstructive pulmonary disease (COPD) are more likely to present serious forms of COVID-19. There are yet no studies c1
The low blood sugar (glucose) levels experienced by people with diabetes can affect the brain. A sudden drop in glucose causes neuronal death and, as1